New Version of Clinical Trial Imaging Management Solution Expands Features for Specific Clinical Areas, Enhances Workflow, Increases Flexibility, and Eases Quality Control Processes
Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions, today announced the newest version of its Corelab-in-a-Box™ (CLIB) Clinical Trial Imaging Management technology solution. This new version provides sponsors with the key functionality of an imaging corelab in a web-based solution bringing security, efficiency, speed, and transparency to what was considered a black box industry. CLIB Version 3.1 has expanded its features for specific clinical areas, such as oncology, dermatology and for echocardiography. It also offers enhanced workflow and increased flexibility and has eased the quality control and data clarification processes.
"Each clinical study has its own requirements. In this version of our Clinical Trial Imaging Management solution, we have made significant enhancements by adding features for oncology and other clinical areas that rely heavily on imaging data during their studies," said Ven Thangaraj, CEO of Radiant Sage. "We have listened to our clients and enhanced our product to help them to more easily facilitate study execution, regulatory compliance and exploratory research."
Some of the enhancements in CLIB Version 3.1 include:
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.